Jasper Therapeutics Inc
JSPR
Get informed when a big investor buys or sells
+ FollowMarket Cap$13.47M
Close$
$1.79
236.4% upside
Current Fair Value
236.4% upsideUndervalued by 236.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $13.47 Million |
|---|---|
| Enterprise Value | $86,381.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.95 |
| Beta | 3.08 |
| Outstanding Shares | 19,168,110 |
Return
| Return on Equity | -818.74% |
|---|---|
| Return on Assets | -131.41% |
| Return on Invested Capital | -601.34% |
Valuation & Multiples
| P/E Ratio | -0.29 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 8.76 |
| Debt to Equity | 0.22 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.46
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 7, 2026
EPS Estimate
$-0.43
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2236▲ 0.38% |
|---|---|
| Total Calls | 125,200▼ 22.04% |
| Total Puts | 28,000▼ 20.68% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 82.50%▼ 33.43% |
|---|---|
| Total Invested | $13.86M▼ 60.58% |
| Investors Holding | 60▲ 2.00% |
ESG Score
No data
About Jasper Therapeutics Inc
3 employees